EverPoint Asset Management’s Charles River Laboratories CRL Stock Holding History

EverPoint Asset Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$5.77M	Buy	+75,700	New	+$5.75M	0.11%	224
2016 Q2	–	Sell	-220,000	Closed	-$16.7M	–	407
2016 Q1	$16.7M	Sell	220,000 -25,000	-10%	-$1.85M	0.33%	75
2015 Q4	$19.7M	Buy	+245,000	New	+$17.7M	0.41%	64
2015 Q1	–	Sell	-250,000	Closed	-$15.9M	–	517
2014 Q4	$15.9M	Hold	250,000	–	–	0.36%	94
2014 Q3	$14.9M	Buy	+250,000	New	+$14.3M	0.34%	81

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

EverPoint Asset Management's CRL Position: Q4 2016 in Review

EverPoint Asset Management opened a new position in Charles River Laboratories (CRL) in Q4 2016: 75,700 shares worth $5.77M. The stake represents 0.11% of the portfolio and ranks #224 among its holdings. This is a return to the name: EverPoint Asset Management previously reported a position in CRL as recently as Q1 2016.

EverPoint Asset Management first reported a position in CRL in Q3 2014 and has held it in 5 quarters since. The position peaked at $19.7M in Q4 2015. 297 funds tracked by Wall St. Rank hold CRL as of Q4 2016.

EverPoint Asset Management held 75,700 shares of Charles River Laboratories worth $5.77M as of Q4 2016.
Charles River Laboratories was a new EverPoint Asset Management position in Q4 2016.
Charles River Laboratories made up 0.11% of EverPoint Asset Management's portfolio in Q4 2016, its #224 holding.
EverPoint Asset Management first reported a position in Charles River Laboratories in Q3 2014 and has held it in 5 quarters since.
EverPoint Asset Management's Charles River Laboratories position peaked at $19.7M in Q4 2015.
297 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2016.

Based on EverPoint Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.